Sprycel and Thyroid diseases - a phase IV clinical study of FDA data

Summary:

Thyroid diseases is reported as a side effect among people who take Sprycel (dasatinib), especially for people who are female, 60+ old, also take Sertraline, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Thyroid diseases when taking Sprycel. It is created by eHealthMe based on reports of 29,638 people who have side effects when taking Sprycel from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Thyroid diseases?

Thyroid diseases is found to be associated with 1,120 drugs and 1,601 conditions by eHealthMe. Check the latest studies of Thyroid diseases.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

29,638 people reported to have side effects when taking Sprycel.
Among them, 32 people (0.11%) have Thyroid diseases.

Among these 32 people:

What is the gender of people who have Thyroid diseases when taking Sprycel? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Thyroid diseases when taking Sprycel? *

What are other drugs people take besides Sprycel? *

What are other side effects people have besides Thyroid diseases? *

Fatigue (feeling of tiredness): 9 people, 28.12%
Constipation: 6 people, 18.75%
Diarrhea: 5 people, 15.62%
Nausea (feeling of having an urge to vomit): 5 people, 15.62%
Hair Loss: 5 people, 15.62%
Abdominal Pain Upper: 5 people, 15.62%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 15.62%
Dizziness: 4 people, 12.50%
Drowsiness: 4 people, 12.50%
Arrhythmias (irregular heartbeat): 4 people, 12.50%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 12.50%
White Blood Cell Count Increased: 2 people, 6.25%
Pain: 2 people, 6.25%
Leukaemia (blood or bone marrow cancer): 2 people, 6.25%
Chest Pain: 2 people, 6.25%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 3.12%
Pancreatitis (inflammation of pancreas): 1 person, 3.12%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 3.12%
High Blood Cholesterol: 1 person, 3.12%
Diabetes: 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and have Thyroid diseases?

- Check whether Thyroid diseases is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprycel:

Sprycel (29,788 reports)

Thyroid diseases treatments and more:

Thyroid diseases (69,468 reports)

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thyroid diseases:

Thyroid diseases (1,120 drugs)

Browse all the conditions that are associated with Thyroid diseases:

Thyroid diseases (1,601 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib (the active ingredients of Sprycel) and Sprycel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.